TTOO - CONSENSUS CO - T2 Biosystems, Inc.

This chart shows the current share price of T2 Biosystems, Inc. (TTOO) on the GURU.Markets platform at . T2 Biosystems, Inc. (TTOO) develops unique rapid sepsis diagnostic systems and possesses exclusive pricing power over its panels. High patent barriers and strict FDA oversight protect the business from competitors. Current development is focused on integrating AI into the T2MR platform to accelerate the detection of bacteria in blood.

As T2 Biosystems, Inc. (TTOO) fights for survival and the commercialization of its sepsis diagnostic systems, the average analyst price target serves as an indicator of the external assessment of the issuer's market potential. This chart aggregates target prices from leading investment banks, establishing an objective fundamental benchmark that allows investors to evaluate the asset's fair value regardless of retail demand volatility.